Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

CC-90001

Generic Name: CC-90001

Drug Type: Small Molecule

Chemical Formula: C_₁₆H_₂₇N_₅O_₂

CAS Number: 1403859-14-2

Unique Ingredient Identifier: JD5ZWE631K

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis

Phase 2

Terminated

Posted: 2019/08/07

Sponsor:Celgene

ID:NCT04048876

A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Dose CC-90001 in Japanese and Caucasian Healthy Subjects

Phase 1

Completed

Posted: 2019/05/22

Sponsor:Celgene

ID:NCT03958864

A Study to Assess the Pharmacokinetics of CC-90001 in Subjects With Mild, Moderate, and Severe Hepatic Impairment Compared With Healthy Subjects

Phase 1

Completed

Posted: 2018/11/15

Sponsor:Celgene

ID:NCT03742882

A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Warfarin, Rosuvastatin, Metformin, Digoxin, and Nintedanib in Healthy Adult Subjects

Phase 1

Completed

Posted: 2017/12/06

Sponsor:Celgene

ID:NCT03363815

A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis

Phase 2

Terminated

Posted: 2017/05/05

Sponsor:Celgene

ID:NCT03142191

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy